BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu J, Wu RC, O’Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer. 2009;9:615-630. [PMID: 19701241 DOI: 10.1038/nrc2695] [Cited by in Crossref: 328] [Cited by in F6Publishing: 327] [Article Influence: 25.2] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Hu B, Qin L, Zhao L, Wang Q, Wang Q, Xu Y, Jiang J. SRC-1 and Twist1 expression positively correlates with a poor prognosis in human breast cancer. Int J Biol Sci 2014;10:396-403. [PMID: 24719557 DOI: 10.7150/ijbs.8193] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
2 Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med 2012;18:1754-67. [PMID: 23223073 DOI: 10.1038/nm.3012] [Cited by in Crossref: 620] [Cited by in F6Publishing: 601] [Article Influence: 68.9] [Reference Citation Analysis]
3 Song J, Zhou S. Post-transcriptional regulation of insect metamorphosis and oogenesis. Cell Mol Life Sci 2020;77:1893-909. [DOI: 10.1007/s00018-019-03361-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
4 Dowd DR, Macdonald PN. Coregulators of VDR-mediated Gene Expression. Vitamin D. Elsevier; 2011. pp. 193-209. [DOI: 10.1016/b978-0-12-381978-9.10010-1] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Haery L, Thompson RC, Gilmore TD. Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy. Genes Cancer 2015;6:184-213. [PMID: 26124919 DOI: 10.18632/genesandcancer.65] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 8.6] [Reference Citation Analysis]
6 Wang L, Li W, Li K, Guo Y, Liu D, Yao Z, Lin X, Li S, Jiang Z, Liu Q, Jiang Y, Zhang B, Chen L, Zhou F, Ren H, Lin D, Zhang D, Yeung SJ, Zhang H. The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma. Cancer Med 2018;7:5205-16. [PMID: 30270520 DOI: 10.1002/cam4.1786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Xue B, Dunker AK, Uversky VN. Retro-MoRFs: identifying protein binding sites by normal and reverse alignment and intrinsic disorder prediction. Int J Mol Sci 2010;11:3725-47. [PMID: 21152297 DOI: 10.3390/ijms11103725] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
8 Judes G, Dagdemir A, Karsli-ceppioglu S, Lebert A, Echegut M, Ngollo M, Bignon Y, Penault-llorca F, Bernard-gallon D. H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes. Epigenomics 2016;8:909-24. [DOI: 10.2217/epi-2016-0015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
9 Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, Van Buren G 2nd, McElhany AL, Fisher WE, Lonard DM, O'Malley BW, Wang J. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett 2019;442:310-9. [PMID: 30423406 DOI: 10.1016/j.canlet.2018.11.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
10 Shi X, Xu W, Dai H, Sun Y, Wang X. The role of SRC1 and SRC2 in steroid-induced SDF1 expression in normal and ectopic endometrium. REPRODUCTION 2014;147:847-53. [DOI: 10.1530/rep-14-0027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
11 Viswakarma N, Jia Y, Bai L, Vluggens A, Borensztajn J, Xu J, Reddy JK. Coactivators in PPAR-Regulated Gene Expression. PPAR Res. 2010;2010. [PMID: 20814439 DOI: 10.1155/2010/250126] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 9.9] [Reference Citation Analysis]
12 Lee Y, Heo J, Jeong H, Hong KT, Kwon DH, Shin MH, Oh M, Sable GA, Ahn GO, Lee JS, Song HK, Lim HS. Targeted Degradation of Transcription Coactivator SRC-1 through the N-Degron Pathway. Angew Chem Int Ed Engl 2020;59:17548-55. [PMID: 33026161 DOI: 10.1002/anie.202005004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Srivastava J, Robertson CL, Ebeid K, Dozmorov M, Rajasekaran D, Mendoza R, Siddiq A, Akiel MA, Jariwala N, Shen XN, Windle JJ, Subler MA, Mukhopadhyay ND, Giashuddin S, Ghosh S, Lai Z, Chen Y, Fisher PB, Salem AK, Sanyal AJ, Sarkar D. A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH). Hepatology 2017;66:466-80. [PMID: 28437865 DOI: 10.1002/hep.29230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
14 Shimizu Y, Tamada S, Kato M, Hirayama Y, Takeyama Y, Iguchi T, Sadar MD, Nakatani T. Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy. J Clin Med 2018;7:E444. [PMID: 30453546 DOI: 10.3390/jcm7110444] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
15 Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ, Li X, Dawson DW, Wu H. Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res 2012;18:1352-63. [PMID: 22261810 DOI: 10.1158/1078-0432.CCR-11-1539] [Cited by in Crossref: 131] [Cited by in F6Publishing: 93] [Article Influence: 13.1] [Reference Citation Analysis]
16 Wang Z, Zhu WG, Xu X. Ubiquitin-like modifications in the DNA damage response. Mutat Res 2017;803-805:56-75. [PMID: 28734548 DOI: 10.1016/j.mrfmmm.2017.07.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
17 Szwarc MM, Kommagani R, Jeong JW, Wu SP, Tsai SY, Tsai MJ, O'Malley BW, DeMayo FJ, Lydon JP. Perturbing the cellular levels of steroid receptor coactivator-2 impairs murine endometrial function. PLoS One 2014;9:e98664. [PMID: 24905738 DOI: 10.1371/journal.pone.0098664] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
18 Motamed M, Rajapakshe KI, Hartig SM, Coarfa C, Moses RE, Lonard DM, O'Malley BW. Steroid receptor coactivator 1 is an integrator of glucose and NAD+/NADH homeostasis. Mol Endocrinol 2014;28:395-405. [PMID: 24438340 DOI: 10.1210/me.2013-1404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
19 Mirza S, Rakha EA, Alshareeda A, Mohibi S, Zhao X, Katafiasz BJ, Wang J, Gurumurthy CB, Bele A, Ellis IO, Green AR, Band H, Band V. Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients. Breast Cancer Res Treat 2013;137:721-31. [PMID: 23288344 DOI: 10.1007/s10549-012-2363-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
20 Wang W, Bian K, Vallabhaneni S, Zhang B, Wu RC, O'Malley BW, Long W. ERK3 promotes endothelial cell functions by upregulating SRC-3/SP1-mediated VEGFR2 expression. J Cell Physiol 2014;229:1529-37. [PMID: 24585635 DOI: 10.1002/jcp.24596] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
21 Salmerón-Hernández Á, Noriega-Reyes MY, Jordan A, Baranda-Avila N, Langley E. BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells. Int J Mol Sci 2019;20:E966. [PMID: 30813351 DOI: 10.3390/ijms20040966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen Z, Shen Z, Zhang Z, Zhao D, Xu L, Zhang L. RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer. Front Genet 2021;12:659788. [PMID: 33841514 DOI: 10.3389/fgene.2021.659788] [Reference Citation Analysis]
23 Sheikh BN. Crafting the brain - role of histone acetyltransferases in neural development and disease. Cell Tissue Res 2014;356:553-73. [PMID: 24788822 DOI: 10.1007/s00441-014-1835-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
24 Jin J, Wang Y, Wang J, Xu Y, Chen S, Wang J, Ran X, Su Y. Increased radiosensitivity and radiation-induced apoptosis in SRC-3 knockout mice. J Radiat Res 2014;55:443-50. [PMID: 24309719 DOI: 10.1093/jrr/rrt132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
25 Shen R, Goonesekere NC, Guda C. Mining functional subgraphs from cancer protein-protein interaction networks. BMC Syst Biol 2012;6 Suppl 3:S2. [PMID: 23282132 DOI: 10.1186/1752-0509-6-S3-S2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 May FE. Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer. Cancer Manag Res 2014;6:225-52. [PMID: 24904222 DOI: 10.2147/CMAR.S35024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
27 Zhang HL, Zhao B, Yang P, Du YQ, Han W, Xu J, Yin DM. Steroid Receptor Coactivator 3 Regulates Synaptic Plasticity and Hippocampus-dependent Memory. Neurosci Bull 2021. [PMID: 34228315 DOI: 10.1007/s12264-021-00741-5] [Reference Citation Analysis]
28 Cai M, Liang X, Sun X, Chen H, Dong Y, Wu L, Gu S, Han S. Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway. Front Oncol 2019;9:164. [PMID: 30941313 DOI: 10.3389/fonc.2019.00164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Qin L, Wu YL, Toneff MJ, Li D, Liao L, Gao X, Bane FT, Tien JC, Xu Y, Feng Z, Yang Z, Xu Y, Theissen SM, Li Y, Young L, Xu J. NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis. Cancer Res 2014;74:3477-88. [PMID: 24769444 DOI: 10.1158/0008-5472.CAN-13-2639] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
30 Tints K, Prink M, Neuman T, Palm K. LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells. Int J Mol Sci 2014;15:5680-98. [PMID: 24705462 DOI: 10.3390/ijms15045680] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
31 Li M, Wang W, Dan Y, Tong Z, Chen W, Qin L, Liu K, Li W, Mo P, Yu C. Downregulation of amplified in breast cancer 1 contributes to the anti-tumor effects of sorafenib on human hepatocellular carcinoma. Oncotarget 2016;7:29605-19. [PMID: 27105488 DOI: 10.18632/oncotarget.8812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
32 Meneses-Morales I, Tecalco-Cruz AC, Barrios-García T, Gómez-Romero V, Trujillo-González I, Reyes-Carmona S, García-Zepeda E, Méndez-Enríquez E, Cervantes-Roldán R, Pérez-Sánchez V, Recillas-Targa F, Mohar-Betancourt A, León-Del-Río A. SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells. Nucleic Acids Res 2014;42:6885-900. [PMID: 24771346 DOI: 10.1093/nar/gku311] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
33 Stashi E, Wang L, Mani SK, York B, O'Malley BW. Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. Mol Endocrinol 2013;27:1776-87. [PMID: 23927929 DOI: 10.1210/me.2013-1192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
34 He B, Lanz RB, Fiskus W, Geng C, Yi P, Hartig SM, Rajapakshe K, Shou J, Wei L, Shah SS, Foley C, Chew SA, Eedunuri VK, Bedoya DJ, Feng Q, Minami T, Mitsiades CS, Frolov A, Weigel NL, Hilsenbeck SG, Rosen DG, Palzkill T, Ittmann MM, Song Y, Coarfa C, O'Malley BW, Mitsiades N. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. Proc Natl Acad Sci U S A 2014;111:18261-6. [PMID: 25489091 DOI: 10.1073/pnas.1421415111] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
35 Yun BH, Jeon YE, Seo SK, Park JH, Yoon SO, Cho S, Choi YS, Lee BS. Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis. Reprod Sci 2015;22:1539-48. [DOI: 10.1177/1933719115589411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
36 Chitilian J, Thillainadesan G, Manias J, Chang W, Walker E, Isovic M, Stanford W, Torchia J. Critical Components of the Pluripotency Network Are Targets for the p300/CBP Interacting Protein (p/CIP) in Embryonic Stem Cells: NCoA3 and Stem Cell Pluripotency. Stem Cells 2014;32:204-15. [DOI: 10.1002/stem.1564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
37 Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson SL, Ponnusamy MP, Jain M, Batra SK. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Oncogene 2015;34:4879-89. [PMID: 25531332 DOI: 10.1038/onc.2014.409] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
38 Stashi E, York B, O'Malley BW. Steroid receptor coactivators: servants and masters for control of systems metabolism. Trends Endocrinol Metab 2014;25:337-47. [PMID: 24953190 DOI: 10.1016/j.tem.2014.05.004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
39 Li M, Wang Y, Xia X, Mo P, Xu J, Yu C, Li W. Steroid receptor coactivator 3 inhibits hepatitis B virus gene expression through activating Akt signaling to prevent HNF4α nuclear translocation. Cell Biosci 2019;9:64. [PMID: 31417670 DOI: 10.1186/s13578-019-0328-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Wei X, Bai L, Dong L, Liu H, Xing P, Zhou Z, Wu S, Lan K. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA. PLoS Pathog 2019;15:e1008160. [PMID: 31751430 DOI: 10.1371/journal.ppat.1008160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Xu Y, Chen Q, Li W, Su X, Chen T, Liu Y, Zhao Y, Yu C. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness. Oncogene 2010;29:3386-97. [DOI: 10.1038/onc.2010.90] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
42 Śliwiński L, Cegieła U, Pytlik M, Folwarczna J, Janas A, Zbrojkiewicz M. Effects of fenoterol on the skeletal system depend on the androgen level. Pharmacol Rep 2017;69:260-7. [PMID: 28126642 DOI: 10.1016/j.pharep.2016.09.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 O'Malley BW. Cellular proteome, coregulators, endocrine system and the human brain: the Regulatory biology of humanism. Aging (Albany NY) 2011;3:22-5. [PMID: 21258135 DOI: 10.18632/aging.100270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Nagalingam A, Tighiouart M, Ryden L, Joseph L, Landberg G, Saxena NK, Sharma D. Med1 plays a critical role in the development of tamoxifen resistance. Carcinogenesis 2012;33:918-30. [PMID: 22345290 DOI: 10.1093/carcin/bgs105] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
45 Chen T, Chen Q, Xu Y, Zhou Q, Zhu J, Zhang H, Wu Q, Xu J, Yu C. SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism. J Hepatol 2012;56:210-7. [PMID: 21827731 DOI: 10.1016/j.jhep.2011.07.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
46 Mou C, Zhang Y, Zhang W, Ding Y, Chen L. Lysine residues 639 and 673 of mouse Ncoa3 are ubiquitination sites for the regulation of its stability. Acta Biochim Biophys Sin (Shanghai) 2014;46:1066-71. [PMID: 25348736 DOI: 10.1093/abbs/gmu096] [Reference Citation Analysis]
47 Rohira AD, Lonard DM, O'Malley BW. Emerging roles of steroid receptor coactivators in stromal cell responses. J Endocrinol 2021;248:R41-50. [PMID: 33337343 DOI: 10.1530/JOE-20-0511] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Antonarakis ES, Armstrong AJ. Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer. Prostate Cancer Prostatic Dis 2011;14:192-205. [PMID: 21577234 DOI: 10.1038/pcan.2011.23] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
49 Ji X, Li N, Yang R, Rao K, Ma M, Wang Z. The steroid receptor coactivator 1 (SRC1) and 3 (SRC3) recruitment as a novel molecular initiating event of 4-n-nonylphenol in estrogen receptor α-mediated pathways. Ecotoxicol Environ Saf 2020;189:109958. [PMID: 31767456 DOI: 10.1016/j.ecoenv.2019.109958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
50 Campbell MJ, Turner BM. Altered histone modifications in cancer. Adv Exp Med Biol 2013;754:81-107. [PMID: 22956497 DOI: 10.1007/978-1-4419-9967-2_4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
51 Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W. MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation. Mol Oncol 2018;12:391-405. [PMID: 29360267 DOI: 10.1002/1878-0261.12173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
52 Johnson AB, O'Malley BW. ERasing breast cancer resistance through the kinome. Nat Med 2011;17:660-1. [PMID: 21647142 DOI: 10.1038/nm0611-660] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
53 Blundon MA, Dasgupta S. Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis. Endocrinology 2019;160:1811-20. [PMID: 31157867 DOI: 10.1210/en.2019-00097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
54 Ribeiro D, Klarqvist MDR, Westermark UK, Oliynyk G, Dzieran J, Kock A, Savatier Banares C, Hertwig F, Johnsen JI, Fischer M, Kogner P, Lovén J, Arsenian Henriksson M. Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients. Cell Rep 2016;16:979-93. [PMID: 27396325 DOI: 10.1016/j.celrep.2016.06.052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
55 Cha JM, Dey SK. Reflections on Rodent Implantation. In: Geisert RD, Bazer FW, editors. Regulation of Implantation and Establishment of Pregnancy in Mammals. Cham: Springer International Publishing; 2015. pp. 69-85. [DOI: 10.1007/978-3-319-15856-3_5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
56 Yu OB, Mutchie TR, Di Milo ES, Arnold LA. Synthesis and biological evaluation of calcioic acid. Steroids 2020;154:108536. [PMID: 31704333 DOI: 10.1016/j.steroids.2019.108536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Apuri S, Sokol L. An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin’s lymphoma. Expert Opinion on Investigational Drugs 2016;25:687-96. [DOI: 10.1517/13543784.2016.1164140] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
58 de Vera IMS, Zheng J, Novick S, Shang J, Hughes TS, Brust R, Munoz-Tello P, Gardner WJ Jr, Marciano DP, Kong X, Griffin PR, Kojetin DJ. Synergistic Regulation of Coregulator/Nuclear Receptor Interaction by Ligand and DNA. Structure 2017;25:1506-1518.e4. [PMID: 28890360 DOI: 10.1016/j.str.2017.07.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
59 Geng CD, Vedeckis WV. A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells. Mol Endocrinol 2011;25:44-57. [PMID: 21084380 DOI: 10.1210/me.2010-0249] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
60 Lonard DM, O'Malley BW. Molecular Pathways: Targeting Steroid Receptor Coactivators in Cancer. Clin Cancer Res 2016;22:5403-7. [PMID: 27654711 DOI: 10.1158/1078-0432.CCR-15-1958] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
61 Zhang Y, Duan C, Bian C, Xiong Y, Zhang J. Steroid receptor coactivator-1: a versatile regulator and promising therapeutic target for breast cancer. J Steroid Biochem Mol Biol 2013;138:17-23. [PMID: 23474438 DOI: 10.1016/j.jsbmb.2013.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
62 Vellky JE, Ricke WA. Development and prevalence of castration-resistant prostate cancer subtypes. Neoplasia 2020;22:566-75. [PMID: 32980775 DOI: 10.1016/j.neo.2020.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
63 Síma M, Havelková H, Quan L, Svobodová M, Jarošíková T, Vojtíšková J, Stassen AP, Demant P, Lipoldová M. Genetic control of resistance to Trypanosoma brucei brucei infection in mice. PLoS Negl Trop Dis 2011;5:e1173. [PMID: 21666791 DOI: 10.1371/journal.pntd.0001173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
64 Li JV, Chien CD, Garee JP, Xu J, Wellstein A, Riegel AT. Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells. Mol Endocrinol 2013;27:1113-27. [PMID: 23660594 DOI: 10.1210/me.2012-1353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
65 Gupta A, Hossain MM, Miller N, Kerin M, Callagy G, Gupta S. NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2α-ATF4 signalling in breast cancer. Oncogene 2016;35:5860-71. [PMID: 27109102 DOI: 10.1038/onc.2016.121] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
66 Hirota Y. Uterine Receptivity in Mouse Embryo Implantation. In: Kanzaki H, editor. Uterine Endometrial Function. Tokyo: Springer Japan; 2016. pp. 11-25. [DOI: 10.1007/978-4-431-55972-6_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Yore MA, Im D, Webb LK, Zhao Y, Chadwick JG Jr, Molenda-Figueira HA, Haidacher SJ, Denner L, Tetel MJ. Steroid receptor coactivator-2 expression in brain and physical associations with steroid receptors. Neuroscience 2010;169:1017-28. [PMID: 20678994 DOI: 10.1016/j.neuroscience.2010.05.053] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
68 Karanian M, Pissaloux D, Gomez-Brouchet A, Chevenet C, Le Loarer F, Fernandez C, Minard V, Corradini N, Castex MP, Duc-Gallet A, Blay JY, Tirode F. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma. Am J Surg Pathol 2020;44:607-16. [PMID: 32187044 DOI: 10.1097/PAS.0000000000001464] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
69 Reineke EL, Benham A, Soibam B, Stashi E, Taegtmeyer H, Entman ML, Schwartz RJ, O'Malley BW. Steroid receptor coactivator-2 is a dual regulator of cardiac transcription factor function. J Biol Chem 2014;289:17721-31. [PMID: 24811170 DOI: 10.1074/jbc.M113.539908] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
70 Kerver HN, Wade J. Seasonal and sexual dimorphisms in expression of androgen receptor and its coactivators in brain and peripheral copulatory tissues of the green anole. General and Comparative Endocrinology 2013;193:56-67. [DOI: 10.1016/j.ygcen.2013.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
71 Santana-Davila R, Perez EA. Treatment options for patients with triple-negative breast cancer. J Hematol Oncol 2010;3:42. [PMID: 20979652 DOI: 10.1186/1756-8722-3-42] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
72 Hossain MM, Barua D, Arabkari V, Islam N, Gupta A, Gupta S. Hyperactivation of nuclear receptor coactivators induces PERK-dependent cell death. Oncotarget 2018;9:11707-21. [PMID: 29545931 DOI: 10.18632/oncotarget.24451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
73 Ma L, Liu W, Xu A, Ji Q, Ma Y, Tai Y, Wang Y, Shen C, Liu Y, Wang T, Han J, Zhao C. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect. Cancer Sci 2020;111:2028-40. [PMID: 32279388 DOI: 10.1111/cas.14412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
74 Takeda K, Hara N, Nishiyama T, Tasaki M, Ishizaki F, Tomita Y. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen. BMC Cancer 2016;16:332. [PMID: 27225190 DOI: 10.1186/s12885-016-2378-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Dasgupta S, Lonard DM, O'Malley BW. Nuclear receptor coactivators: master regulators of human health and disease. Annu Rev Med 2014;65:279-92. [PMID: 24111892 DOI: 10.1146/annurev-med-051812-145316] [Cited by in Crossref: 119] [Cited by in F6Publishing: 106] [Article Influence: 13.2] [Reference Citation Analysis]
76 Khan SH, Awasthi S, Guo C, Goswami D, Ling J, Griffin PR, Simons SS Jr, Kumar R. Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations. J Biol Chem 2012;287:44546-60. [PMID: 23132854 DOI: 10.1074/jbc.M112.411330] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
77 Kumar R. Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting. Asian J Androl 2016;18:682-6. [PMID: 27364545 DOI: 10.4103/1008-682X.183380] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
78 Cha J, Dey SK, Lim H(. Embryo Implantation. Knobil and Neill's Physiology of Reproduction. Elsevier; 2015. pp. 1697-739. [DOI: 10.1016/b978-0-12-397175-3.00038-7] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
79 Madak-Erdogan Z, Charn TH, Jiang Y, Liu ET, Katzenellenbogen JA, Katzenellenbogen BS. Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Mol Syst Biol 2013;9:676. [PMID: 23774759 DOI: 10.1038/msb.2013.28] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 7.4] [Reference Citation Analysis]
80 York B, O'Malley BW. Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem 2010;285:38743-50. [PMID: 20956538 DOI: 10.1074/jbc.R110.193367] [Cited by in Crossref: 150] [Cited by in F6Publishing: 86] [Article Influence: 12.5] [Reference Citation Analysis]
81 Li W, Fu J, Bian C, Zhang J, Xie Z. Immunohistochemical localization of steroid receptor coactivators in chondrosarcoma: an in vivo tissue microarray study. Pathol Res Pract 2014;210:1005-10. [PMID: 24875297 DOI: 10.1016/j.prp.2014.04.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
82 Lu H, Cui JY, Gunewardena S, Yoo B, Zhong XB, Klaassen CD. Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing. Epigenetics 2012;7:914-29. [PMID: 22772165 DOI: 10.4161/epi.21113] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
83 Wang F, Yang W, Shi Y, Le G. Probing the structural requirements for thyroid hormone receptor inhibitory activity of sulfonylnitrophenylthiazoles (SNPTs) using 2D-QSAR and 3D-QSAR approaches. Med Chem Res 2017;26:344-60. [DOI: 10.1007/s00044-016-1751-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, Roeder RG, Zhang X. Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc Natl Acad Sci U S A 2010;107:6765-70. [PMID: 20351249 DOI: 10.1073/pnas.1001814107] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
85 Duan Z, Zou JX, Yang P, Wang Y, Borowsky AD, Gao AC, Chen HW. Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex. Prostate 2013;73:455-66. [PMID: 23038103 DOI: 10.1002/pros.22587] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
86 Park SM, Kang TI, So JS. Roles of XBP1s in Transcriptional Regulation of Target Genes. Biomedicines 2021;9:791. [PMID: 34356855 DOI: 10.3390/biomedicines9070791] [Reference Citation Analysis]
87 Mertens F, Antonescu CR, Mitelman F. Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes. Genes Chromosomes Cancer 2016;55:291-310. [PMID: 26684580 DOI: 10.1002/gcc.22335] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 9.4] [Reference Citation Analysis]
88 Luo F, Li W, Zhang J, Huang K, Fu J, Xie Z. Overexpression of steroid receptor coactivator-3 in bone cancers: an in vivo immunohistochemical study with tissue microarray. Pathol Res Pract 2013;209:790-6. [PMID: 24134957 DOI: 10.1016/j.prp.2013.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
89 Huang SC, Ghossein RA, Bishop JA, Zhang L, Chen TC, Huang HY, Antonescu CR. Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation. Am J Surg Pathol 2016;40:51-9. [PMID: 26371783 DOI: 10.1097/PAS.0000000000000492] [Cited by in Crossref: 51] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
90 Tanaka K, Martinez GJ, Yan X, Long W, Ichiyama K, Chi X, Kim BS, Reynolds JM, Chung Y, Tanaka S, Liao L, Nakanishi Y, Yoshimura A, Zheng P, Wang X, Tian Q, Xu J, O'Malley BW, Dong C. Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3. Cell Rep 2018;23:2318-29. [PMID: 29791844 DOI: 10.1016/j.celrep.2018.04.088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
91 Szwarc MM, Kommagani R, Putluri V, Dubrulle J, Stossi F, Mancini MA, Coarfa C, Lanz RB, Putluri N, DeMayo FJ, Lydon JP, O'Malley BW. Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells. Sci Rep 2018;8:13134. [PMID: 30177747 DOI: 10.1038/s41598-018-31372-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
92 Yi P, Xia W, Wu RC, Lonard DM, Hung MC, O'Malley BW. SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization. Genes Dev 2013;27:274-87. [PMID: 23388826 DOI: 10.1101/gad.203760.112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
93 Peng M, Zhao G, Yang F, Cheng G, Huang J, Qin X, Liu Y, Wang Q, Li Y, Qin D. NCOA1 is a novel susceptibility gene for multiple myeloma in the Chinese population: A case-control study. PLoS One 2017;12:e0173298. [PMID: 28264017 DOI: 10.1371/journal.pone.0173298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
94 Rohira AD, Yan F, Wang L, Wang J, Zhou S, Lu A, Yu Y, Xu J, Lonard DM, O'Malley BW. Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells. Cancer Res 2017;77:4293-304. [PMID: 28611048 DOI: 10.1158/0008-5472.CAN-16-2982] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
95 Johnson RL, Hwang JY, Arnold LA, Huang R, Wichterman J, Augustinaite I, Austin CP, Inglese J, Guy RK, Huang W. A quantitative high-throughput screen identifies novel inhibitors of the interaction of thyroid receptor beta with a peptide of steroid receptor coactivator 2. J Biomol Screen 2011;16:618-27. [PMID: 21482722 DOI: 10.1177/1087057111402199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
96 Feng Q, O'Malley BW. Nuclear receptor modulation--role of coregulators in selective estrogen receptor modulator (SERM) actions. Steroids 2014;90:39-43. [PMID: 24945111 DOI: 10.1016/j.steroids.2014.06.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
97 Chandrasekar T, Yang JC, Gao AC, Evans CP. Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Transl Androl Urol 2015;4:365-80. [PMID: 26814148 DOI: 10.3978/j.issn.2223-4683.2015.05.02] [Cited by in F6Publishing: 115] [Reference Citation Analysis]
98 Kalashnikova EV, Revenko AS, Gemo AT, Andrews NP, Tepper CG, Zou JX, Cardiff RD, Borowsky AD, Chen HW. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res 2010;70:9402-12. [PMID: 20864510 DOI: 10.1158/0008-5472.CAN-10-1199] [Cited by in Crossref: 110] [Cited by in F6Publishing: 69] [Article Influence: 9.2] [Reference Citation Analysis]
99 Rollins DA, Kharlyngdoh JB, Coppo M, Tharmalingam B, Mimouna S, Guo Z, Sacta MA, Pufall MA, Fisher RP, Hu X, Chinenov Y, Rogatsky I. Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages. Nat Commun 2017;8:1739. [PMID: 29170386 DOI: 10.1038/s41467-017-01569-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
100 Meng X, Zhao Y, Liu J, Wang L, Dong Z, Zhang T, Gu X, Zheng Z. Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer. Exp Ther Med 2019;18:2219-30. [PMID: 31452712 DOI: 10.3892/etm.2019.7808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Zhang Y, Shi W. Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling. Biochem Cell Biol 2019;97:488-96. [PMID: 30532986 DOI: 10.1139/bcb-2018-0114] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Yu Y, Chen C, Huo G, Deng J, Zhao H, Xu R, Jiang L, Chen S, Wang S. ATP1A1 Integrates AKT and ERK Signaling via Potential Interaction With Src to Promote Growth and Survival in Glioma Stem Cells. Front Oncol 2019;9:320. [PMID: 31114755 DOI: 10.3389/fonc.2019.00320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
103 Dey P, Barros RP, Warner M, Ström A, Gustafsson JÅ. Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS. J Mol Endocrinol 2013;51:T61-74. [PMID: 24031087 DOI: 10.1530/JME-13-0150] [Cited by in Crossref: 64] [Cited by in F6Publishing: 37] [Article Influence: 7.1] [Reference Citation Analysis]
104 Chen X, Liu Z, Xu J. The cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survival. Mol Endocrinol 2010;24:1917-34. [PMID: 20685850 DOI: 10.1210/me.2010-0201] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
105 Ochnik AM, Peterson MS, Avdulov SV, Oh AS, Bitterman PB, Yee D. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells. Neoplasia 2016;18:100-10. [PMID: 26936396 DOI: 10.1016/j.neo.2016.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
106 Liu H, Li HM, Yue Y, Song ZH, Wang JJ, Dou W. The alternative splicing of BdTai and its involvement in the development of Bactrocera dorsalis (Hendel). J Insect Physiol 2017;101:132-41. [PMID: 28750998 DOI: 10.1016/j.jinsphys.2017.07.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
107 Durlacher CT, Chow K, Chen XW, He ZX, Zhang X, Yang T, Zhou SF. Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment. Clin Exp Pharmacol Physiol 2015;42:427-43. [PMID: 25739707 DOI: 10.1111/1440-1681.12385] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
108 Cussol L, Mauran‐ambrosino L, Buratto J, Belorusova AY, Neuville M, Osz J, Fribourg S, Fremaux J, Dolain C, Goudreau SR, Rochel N, Guichard G. Structural Basis for α‐Helix Mimicry and Inhibition of Protein–Protein Interactions with Oligourea Foldamers. Angew Chem Int Ed 2021;60:2296-303. [DOI: 10.1002/anie.202008992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
109 Eedunuri VK, Rajapakshe K, Fiskus W, Geng C, Chew SA, Foley C, Shah SS, Shou J, Mohamed JS, Coarfa C, O'Malley BW, Mitsiades N. miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation. Mol Endocrinol 2015;29:1170-83. [PMID: 26066330 DOI: 10.1210/me.2015-1080] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
110 Szwarc MM, Hai L, Gibbons WE, White LD, Mo Q, Kommagani R, Lanz RB, DeMayo FJ, O'Malley BW, Lydon JP. Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics. Reproduction 2018;156:387-95. [PMID: 30325183 DOI: 10.1530/REP-18-0282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
111 Cornelissen LM, Henneman L, Drenth AP, Schut E, de Bruijn R, Klarenbeek S, Zwart W, Jonkers J. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice. J Mammary Gland Biol Neoplasia 2019;24:305-21. [PMID: 31729597 DOI: 10.1007/s10911-019-09437-z] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Zhang H, Liu E. Spectroscopic and molecular modeling investigation on the binding of a synthesized steroidal amide to protein. Journal of Luminescence 2014;153:182-7. [DOI: 10.1016/j.jlumin.2014.03.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
113 Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches. F1000Res 2021;10:127. [PMID: 33968364 DOI: 10.12688/f1000research.50850.3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Nakles RE, Shiffert MT, Díaz-Cruz ES, Cabrera MC, Alotaiby M, Miermont AM, Riegel AT, Furth PA. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content. Mol Endocrinol 2011;25:549-63. [PMID: 21292825 DOI: 10.1210/me.2010-0114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
115 Rollins DA, Coppo M, Rogatsky I. Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism. Mol Endocrinol 2015;29:502-17. [PMID: 25647480 DOI: 10.1210/me.2015-1005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
116 Knudsen KE, Penning TM. Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab 2010;21:315-24. [PMID: 20138542 DOI: 10.1016/j.tem.2010.01.002] [Cited by in Crossref: 201] [Cited by in F6Publishing: 194] [Article Influence: 16.8] [Reference Citation Analysis]
117 Yan F, Yu Y, Chow DC, Palzkill T, Madoux F, Hodder P, Chase P, Griffin PR, O'Malley BW, Lonard DM. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor. PLoS One 2014;9:e95243. [PMID: 24743578 DOI: 10.1371/journal.pone.0095243] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
118 Kato M, Banuelos CA, Imamura Y, Leung JK, Caley DP, Wang J, Mawji NR, Sadar MD. Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer. Clin Cancer Res 2016;22:2744-54. [PMID: 26712685 DOI: 10.1158/1078-0432.CCR-15-2119] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
119 Zhao F, Xie X, Tan X, Yu H, Tian M, Lv H, Qin C, Qi J, Zhu Q. The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis. Front Immunol 2021;12:691766. [PMID: 34456908 DOI: 10.3389/fimmu.2021.691766] [Reference Citation Analysis]
120 Mendelson CR, Gao L, Montalbano AP. Multifactorial Regulation of Myometrial Contractility During Pregnancy and Parturition. Front Endocrinol (Lausanne) 2019;10:714. [PMID: 31708868 DOI: 10.3389/fendo.2019.00714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
121 Dasgupta S, O'Malley BW. Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology. J Mol Endocrinol 2014;53:R47-59. [PMID: 25024406 DOI: 10.1530/JME-14-0080] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
122 Srinivasan S, Nwachukwu JC, Parent AA, Cavett V, Nowak J, Hughes TS, Kojetin DJ, Katzenellenbogen JA, Nettles KW. Ligand-binding dynamics rewire cellular signaling via estrogen receptor-α. Nat Chem Biol 2013;9:326-32. [PMID: 23524984 DOI: 10.1038/nchembio.1214] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
123 Zhang X, Peng D, Xi Y, Yuan C, Sagum CA, Klein BJ, Tanaka K, Wen H, Kutateladze TG, Li W, Bedford MT, Shi X. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression. Nat Commun 2016;7:10810. [PMID: 26960573 DOI: 10.1038/ncomms10810] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
124 Maurya VK, DeMayo FJ, Lydon JP. Illuminating the "Black Box" of Progesterone-Dependent Embryo Implantation Using Engineered Mice. Front Cell Dev Biol 2021;9:640907. [PMID: 33898429 DOI: 10.3389/fcell.2021.640907] [Reference Citation Analysis]
125 Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene 2013;32:5501-11. [PMID: 23752182 DOI: 10.1038/onc.2013.206] [Cited by in Crossref: 400] [Cited by in F6Publishing: 382] [Article Influence: 44.4] [Reference Citation Analysis]
126 Deblois G, Giguère V. Reprogramming clinical outcome. Nature 2012;481:275-6. [DOI: 10.1038/481275a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
127 Fenne IS, Helland T, Flågeng MH, Dankel SN, Mellgren G, Sagen JV. Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells. PLoS One 2013;8:e70096. [PMID: 23936147 DOI: 10.1371/journal.pone.0070096] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
128 Green SM, Mostaghel EA, Nelson PS. Androgen action and metabolism in prostate cancer. Mol Cell Endocrinol 2012;360:3-13. [PMID: 22453214 DOI: 10.1016/j.mce.2011.09.046] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 11.5] [Reference Citation Analysis]
129 Simeonova I, Lejour V, Bardot B, Bouarich-Bourimi R, Morin A, Fang M, Charbonnier L, Toledo F. Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes. PLoS Genet 2012;8:e1002731. [PMID: 22761580 DOI: 10.1371/journal.pgen.1002731] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
130 Wyatt AW, Gleave ME. Targeting the adaptive molecular landscape of castration-resistant prostate cancer. EMBO Mol Med 2015;7:878-94. [PMID: 25896606 DOI: 10.15252/emmm.201303701] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 13.7] [Reference Citation Analysis]
131 Geng S, Wang X, Xu X, Zhang H, Ma Y, Zhang Y, Li B, Bi Z, Yang C. Steroid receptor co-activator-3 promotes osteosarcoma progression through up-regulation of FoxM1. Tumor Biol 2014;35:3087-94. [DOI: 10.1007/s13277-013-1406-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
132 Tien JC, Liao L, Liu Y, Liu Z, Lee DK, Wang F, Xu J. The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate. Int J Biol Sci 2014;10:1116-27. [PMID: 25332686 DOI: 10.7150/ijbs.10236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
133 Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, Noh DY, Ahn SH, Lee JW, Kim MK, Jee SH, Wen W, Bolla MK, Wang Q, Dennis J, Michailidou K, Shah M, Conroy DM, Harrington PA, Mayes R, Czene K, Hall P, Teras LR, Patel AV, Couch FJ, Olson JE, Sawyer EJ, Roylance R, Bojesen SE, Flyger H, Lambrechts D, Baten A, Matsuo K, Ito H, Guénel P, Truong T, Keeman R, Schmidt MK, Wu AH, Tseng CC, Cox A, Cross SS, kConFab Investigators, Andrulis IL, Hopper JL, Southey MC, Wu PE, Shen CY, Fasching PA, Ekici AB, Muir K, Lophatananon A, Brenner H, Arndt V, Jones ME, Swerdlow AJ, Hoppe R, Ko YD, Hartman M, Li J, Mannermaa A, Hartikainen JM, Benitez J, González-Neira A, Haiman CA, Dörk T, Bogdanova NV, Teo SH, Mohd Taib NA, Fletcher O, Johnson N, Grip M, Winqvist R, Blomqvist C, Nevanlinna H, Lindblom A, Wendt C, Kristensen VN, Nbcs Collaborators, Tollenaar RAEM, Heemskerk-Gerritsen BAM, Radice P, Bonanni B, Hamann U, Manoochehri M, Lacey JV, Martinez ME, Dunning AM, Pharoah PDP, Easton DF, Yoo KY, Kang D. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? Cancers (Basel) 2021;13:2370. [PMID: 34069208 DOI: 10.3390/cancers13102370] [Reference Citation Analysis]
134 Kommagani R, Szwarc MM, Kovanci E, Creighton CJ, O'Malley BW, Demayo FJ, Lydon JP. A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. Biol Reprod 2014;90:75. [PMID: 24571987 DOI: 10.1095/biolreprod.114.117531] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
135 Li S, Zhang H, Yu Y, Liu M, Guo D, Zhang X, Zhang J. Imbalanced expression pattern of steroid receptor coactivator-1 and -3 in liver cancer compared with normal liver: An immunohistochemical study with tissue microarray. Oncol Lett 2018;16:6339-48. [PMID: 30405769 DOI: 10.3892/ol.2018.9443] [Reference Citation Analysis]
136 Reineke EL, York B, Stashi E, Chen X, Tsimelzon A, Xu J, Newgard CB, Taffet GE, Taegtmeyer H, Entman ML, O'Malley BW. SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. PLoS One 2012;7:e53395. [PMID: 23300926 DOI: 10.1371/journal.pone.0053395] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
137 Sen A, O'Malley K, Wang Z, Raj GV, Defranco DB, Hammes SR. Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 2010;285:28787-95. [PMID: 20628053 DOI: 10.1074/jbc.M110.134064] [Cited by in Crossref: 71] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
138 Shin S, Oh S, An S, Janknecht R. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells. Oncol Rep 2013;29:306-14. [PMID: 23076342 DOI: 10.3892/or.2012.2079] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
139 Robbins D, Chen T. Tissue-specific regulation of pregnane X receptor in cancer development and therapy. Cell Biosci 2014;4:17. [PMID: 24690092 DOI: 10.1186/2045-3701-4-17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
140 Hernández-Hernández OT, González-García TK, Camacho-Arroyo I. Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines. J Steroid Biochem Mol Biol 2012;132:127-34. [PMID: 22542550 DOI: 10.1016/j.jsbmb.2012.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
141 Lee Y, Yoon H, Hwang S, Shin M, Lee JH, Oh M, Im S, Song J, Lim H. Targeted Inhibition of the NCOA1/STAT6 Protein–Protein Interaction. J Am Chem Soc 2017;139:16056-9. [DOI: 10.1021/jacs.7b08972] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
142 Geng C, He B, Xu L, Barbieri CE, Eedunuri VK, Chew SA, Zimmermann M, Bond R, Shou J, Li C, Blattner M, Lonard DM, Demichelis F, Coarfa C, Rubin MA, Zhou P, O'Malley BW, Mitsiades N. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A 2013;110:6997-7002. [PMID: 23559371 DOI: 10.1073/pnas.1304502110] [Cited by in Crossref: 152] [Cited by in F6Publishing: 141] [Article Influence: 16.9] [Reference Citation Analysis]
143 Sun F, Indran IR, Zhang ZW, Tan MH, Li Y, Lim ZL, Hua R, Yang C, Soon FF, Li J, Xu HE, Cheung E, Yong EL. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants. Carcinogenesis 2015;36:757-68. [PMID: 25908644 DOI: 10.1093/carcin/bgv040] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
144 Hartig SM, He B, Long W, Buehrer BM, Mancini MA. Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. J Cell Biol 2011;192:55-67. [PMID: 21220509 DOI: 10.1083/jcb.201004026] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
145 Chang AK, Wu H. The role of AIB1 in breast cancer. Oncol Lett 2012;4:588-94. [PMID: 23226788 DOI: 10.3892/ol.2012.803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
146 Smith CL, Migliaccio I, Chaubal V, Wu MF, Pace MC, Hartmaier R, Jiang S, Edwards DP, Gutiérrez MC, Hilsenbeck SG, Oesterreich S. Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence. Breast Cancer Res Treat 2012;136:253-65. [PMID: 23015261 DOI: 10.1007/s10549-012-2262-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
147 Chen L, Zhang Z, Qiu J, Zhang L, Luo X, Jang J. Chaperonin CCT-mediated AIB1 folding promotes the growth of ERα-positive breast cancer cells on hard substrates. PLoS One 2014;9:e96085. [PMID: 24788909 DOI: 10.1371/journal.pone.0096085] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
148 Tan MH, Li J, Xu HE, Melcher K, Yong EL. Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin 2015;36:3-23. [PMID: 24909511 DOI: 10.1038/aps.2014.18] [Cited by in Crossref: 313] [Cited by in F6Publishing: 280] [Article Influence: 39.1] [Reference Citation Analysis]
149 Zhou Z, Qiao JX, Shetty A, Wu G, Huang Y, Davidson NE, Wan Y. Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci 2014;71:1549. [PMID: 25031550 DOI: 10.1007/s00018-013-1376-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
150 Garee JP, Chien CD, Li JV, Wellstein A, Riegel AT. Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex. Mol Endocrinol 2014;28:846-59. [PMID: 24678732 DOI: 10.1210/me.2013-1379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
151 Tong Z, Li M, Wang W, Mo P, Yu L, Liu K, Ren W, Li W, Zhang H, Xu J, Yu C. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling. J Biol Chem 2015;290:18596-608. [PMID: 26082485 DOI: 10.1074/jbc.M115.640490] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
152 Green CD, Han JJ. Epigenetic regulation by nuclear receptors. Epigenomics 2011;3:59-72. [DOI: 10.2217/epi.10.75] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
153 Chen Y, Sun Y, Zhao W, Ma Y, Yan Z, Nie X. Elevated SRC3 expression predicts pemetrexed resistance in lung adenocarcinoma. Biomed Pharmacother 2020;125:109958. [PMID: 32036219 DOI: 10.1016/j.biopha.2020.109958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Wang M, Zhao F, Li S, Chang AK, Jia Z, Chen Y, Xu F, Pan H, Wu H. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation. PLoS One 2013;8:e65556. [PMID: 23762395 DOI: 10.1371/journal.pone.0065556] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
155 El Bounkari O, Bernhagen J. MIF and autophagy: a novel link beyond "eating". Cell Res 2012;22:950-3. [PMID: 22565285 DOI: 10.1038/cr.2012.76] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
156 Nadal R, Taplin ME, Bellmunt J. Enzalutamide for the treatment of prostate cancer: results and implications of the AFFIRM trial. Future Oncol 2014;10:351-62. [PMID: 24559444 DOI: 10.2217/fon.13.275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
157 Coradini D, Boracchi P, Ambrogi F, Biganzoli E, Oriana S. Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ. Int J Surg Oncol 2012;2012:984346. [PMID: 22577534 DOI: 10.1155/2012/984346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
158 di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-egly C, Lo-coco F, Ascenzi P, Nervi C. Retinoic acid receptors: From molecular mechanisms to cancer therapy. Molecular Aspects of Medicine 2015;41:1-115. [DOI: 10.1016/j.mam.2014.12.003] [Cited by in Crossref: 176] [Cited by in F6Publishing: 151] [Article Influence: 25.1] [Reference Citation Analysis]
159 Peirs S, Van der Meulen J, Van de Walle I, Taghon T, Speleman F, Poppe B, Van Vlierberghe P. Epigenetics in T-cell acute lymphoblastic leukemia. Immunol Rev 2015;263:50-67. [PMID: 25510271 DOI: 10.1111/imr.12237] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
160 Jin C, Zhang X, Sun M, Zhang Y, Zhang G, Wang B. Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers. Onco Targets Ther 2016;9:5483-8. [PMID: 27660465 DOI: 10.2147/OTT.S102386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
161 Al-Otaiby M, Tassi E, Schmidt MO, Chien CD, Baker T, Salas AG, Xu J, Furlong M, Schlegel R, Riegel AT, Wellstein A. Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing. Am J Pathol 2012;180:1474-84. [PMID: 22342158 DOI: 10.1016/j.ajpath.2011.12.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
162 Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat Rev Cancer 2013;13:827-41. [PMID: 24263188 DOI: 10.1038/nrc3621] [Cited by in Crossref: 132] [Cited by in F6Publishing: 122] [Article Influence: 16.5] [Reference Citation Analysis]
163 Cervantes-Badillo MG, Paredes-Villa A, Gómez-Romero V, Cervantes-Roldán R, Arias-Romero LE, Villamar-Cruz O, González-Montiel M, Barrios-García T, Cabrera-Quintero AJ, Rodríguez-Gómez G, Cancino-Villeda L, Zentella-Dehesa A, León-Del-Río A. IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells. Front Endocrinol (Lausanne) 2020;11:568375. [PMID: 33117284 DOI: 10.3389/fendo.2020.568375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
164 Mani RS. The emerging role of speckle-type POZ protein (SPOP) in cancer development. Drug Discov Today 2014;19:1498-502. [PMID: 25058385 DOI: 10.1016/j.drudis.2014.07.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
165 Liu Y, Tong Z, Li T, Chen Q, Zhuo L, Li W, Wu RC, Yu C. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness. Hepatology. 2012;56:1015-1024. [PMID: 22473901 DOI: 10.1002/hep.25751] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
166 Falke LL, Broekhuizen R, Huitema A, Maarseveen E, Nguyen TQ, Goldschmeding R. Tamoxifen for induction of Cre-recombination may confound fibrosis studies in female mice. J Cell Commun Signal 2017;11:205-11. [PMID: 28497232 DOI: 10.1007/s12079-017-0390-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
167 Szwarc MM, Kommagani R, Lessey BA, Lydon JP. The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction. Biol Reprod 2014;91:122. [PMID: 25297546 DOI: 10.1095/biolreprod.114.125021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
168 Wang L, Lonard DM, O'Malley BW. The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets. Horm Cancer 2016;7:229-35. [PMID: 27125199 DOI: 10.1007/s12672-016-0261-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
169 Zhang HL, Han W, Du YQ, Zhao B, Yang P, Yin DM. SRC3 acetylates calmodulin in the mouse brain to regulate synaptic plasticity and fear learning. J Biol Chem 2021;297:101044. [PMID: 34358562 DOI: 10.1016/j.jbc.2021.101044] [Reference Citation Analysis]
170 Balthazart J. Membrane-initiated actions of sex steroids and reproductive behavior: A historical account. Mol Cell Endocrinol 2021;538:111463. [PMID: 34582978 DOI: 10.1016/j.mce.2021.111463] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Suo J, Snider SJ, Mills GB, Creighton CJ, Chen AC, Schiff R, Lloyd RE, Chang EC. Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium. Oncogene 2011;30:724-36. [PMID: 20890303 DOI: 10.1038/onc.2010.445] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
172 Mo P, Zhou Q, Guan L, Wang Y, Wang W, Miao M, Tong Z, Li M, Majaz S, Liu Y. Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling. Oncogene. 2015;34:3935-3945. [PMID: 25263446 DOI: 10.1038/onc.2014.324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
173 Barua D, Abbasi B, Gupta A, Gupta S. XBP1 increases transactivation of somatic mutants of ESR1 and loss of XBP1 reverses endocrine resistance conferred by gain-of-function Y537S ESR1 mutation. Heliyon 2020;6:e05217. [PMID: 33088967 DOI: 10.1016/j.heliyon.2020.e05217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Jin Y, Möller E, Nord KH, Mandahl N, Von Steyern FV, Domanski HA, Mariño-enríquez A, Magnusson L, Nilsson J, Sciot R, Fletcher CDM, Debiec-rychter M, Mertens F. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosom Cancer 2012;51:510-20. [DOI: 10.1002/gcc.21939] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 9.0] [Reference Citation Analysis]
175 Kawagoe J, Li Q, Mussi P, Liao L, Lydon JP, DeMayo FJ, Xu J. Nuclear receptor coactivator-6 attenuates uterine estrogen sensitivity to permit embryo implantation. Dev Cell 2012;23:858-65. [PMID: 23079602 DOI: 10.1016/j.devcel.2012.09.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
176 McNamara KM, Kannai A, Sasano H. Possible roles for glucocorticoid signalling in breast cancer. Mol Cell Endocrinol 2018;466:38-50. [PMID: 28687451 DOI: 10.1016/j.mce.2017.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
177 Sliwiński L, Folwarczna J, Pytlik M, Cegieła U, Nowińska B, Trzeciak H, Trzeciak HI. Do effects of propranolol on the skeletal system depend on the estrogen status?Pharmacol Rep. 2013;65:1345-1356. [PMID: 24399731 DOI: 10.1016/s1734-1140(13)71493-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
178 Obeid JP, Zafar N, El Hokayem J. Steroid Hormone Receptor Coregulators in Endocrine Cancers. IUBMB Life 2016;68:504-15. [PMID: 27240871 DOI: 10.1002/iub.1517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
179 Zhou Y, Bolton EC, Jones JO. Androgens and androgen receptor signaling in prostate tumorigenesis. J Mol Endocrinol 2015;54:R15-29. [PMID: 25351819 DOI: 10.1530/JME-14-0203] [Cited by in Crossref: 84] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
180 Möcklinghoff S, Rose R, Carraz M, Visser A, Ottmann C, Brunsveld L. Synthesis and crystal structure of a phosphorylated estrogen receptor ligand binding domain. Chembiochem 2010;11:2251-4. [PMID: 20922740 DOI: 10.1002/cbic.201000532] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
181 Wagner M, Koslowski M, Paret C, Schmidt M, Türeci O, Sahin U. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells. BMC Cancer 2013;13:570. [PMID: 24304549 DOI: 10.1186/1471-2407-13-570] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
182 Wu Z, Yang M, Liu H, Guo H, Wang Y, Cheng H, Chen L. Role of nuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenance. J Biol Chem 2012;287:38295-304. [PMID: 22977234 DOI: 10.1074/jbc.M112.373092] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
183 Kommagani R, Szwarc MM, Kovanci E, Gibbons WE, Putluri N, Maity S, Creighton CJ, Sreekumar A, DeMayo FJ, Lydon JP, O'Malley BW. Acceleration of the glycolytic flux by steroid receptor coactivator-2 is essential for endometrial decidualization. PLoS Genet 2013;9:e1003900. [PMID: 24204309 DOI: 10.1371/journal.pgen.1003900] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
184 Qin L, Chen J, Lu D, Jain P, Yu Y, Cardenas D, Peng X, Yu X, Xu J, Wang J, O'Malley BW, Lonard DM. Development of improved SRC-3 inhibitors as breast cancer therapeutic agents. Endocr Relat Cancer 2021;28:657-70. [PMID: 34310341 DOI: 10.1530/ERC-20-0402] [Reference Citation Analysis]
185 Tan D, Zhang W, Tao Y, Galiya Y, Wang M. PZR promotes metastasis of colorectal cancer through increasing FAK and Src phosphorylation. Acta Biochim Biophys Sin (Shanghai) 2019;51:356-64. [PMID: 30877754 DOI: 10.1093/abbs/gmz019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
186 Usman RM, Razzaq F, Akbar A, Farooqui AA, Iftikhar A, Latif A, Hassan H, Zhao J, Carew JS, Nawrocki ST, Anwer F. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. Asia Pac J Clin Oncol 2021;17:193-208. [PMID: 32970929 DOI: 10.1111/ajco.13449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
187 Li W, Yan Y, Zheng Z, Zhu Q, Long Q, Sui S, Luo M, Chen M, Li Y, Hua Y, Deng W, Lai R, Li L. Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma. Cell Death Dis 2020;11:1011. [PMID: 33239622 DOI: 10.1038/s41419-020-03218-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
188 Liu X, Li H, Rajurkar M, Li Q, Cotton JL, Ou J, Zhu LJ, Goel HL, Mercurio AM, Park JS, Davis RJ, Mao J. Tead and AP1 Coordinate Transcription and Motility. Cell Rep 2016;14:1169-80. [PMID: 26832411 DOI: 10.1016/j.celrep.2015.12.104] [Cited by in Crossref: 109] [Cited by in F6Publishing: 101] [Article Influence: 18.2] [Reference Citation Analysis]
189 Choi SR, Wang HM, Shin MH, Lim HS. Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1. Int J Mol Sci 2021;22:6407. [PMID: 34203850 DOI: 10.3390/ijms22126407] [Reference Citation Analysis]
190 Chen X, Qin L, Liu Z, Liao L, Martin JF, Xu J. Knockout of SRC-1 and SRC-3 in Mice Decreases Cardiomyocyte Proliferation and Causes a Noncompaction Cardiomyopathy Phenotype. Int J Biol Sci 2015;11:1056-72. [PMID: 26221073 DOI: 10.7150/ijbs.12408] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
191 Kefalopoulou Z, Tzelepi V, Zolota V, Grivas PD, Christopoulos C, Kalofonos H, Maraziotis T, Sotiropoulou-Bonikou G. Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J Neurooncol 2012;106:23-31. [PMID: 21735116 DOI: 10.1007/s11060-011-0637-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
192 Wang Z, Song Y, Ye M, Dai X, Zhu X, Wei W. The diverse roles of SPOP in prostate cancer and kidney cancer. Nat Rev Urol 2020;17:339-50. [PMID: 32355326 DOI: 10.1038/s41585-020-0314-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
193 Jin J, Wang Y, Wang J, Xu Y, Chen SL, Wang JP, Su YP. Impaired hematopoiesis and delayed thrombopoietic recovery following sublethal irradiation in SRC‑3 knockout mice. Mol Med Rep 2014;9:1629-33. [PMID: 24626603 DOI: 10.3892/mmr.2014.2043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
194 Gilad Y, Eliaz Y, Yu Y, Dean AM, Han SJ, Qin L, O'Malley BW, Lonard DM. A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells. Commun Biol 2021;4:399. [PMID: 33767353 DOI: 10.1038/s42003-021-01929-1] [Reference Citation Analysis]
195 Luo A, Zhang X. ERRF is essential for Estrogen-Estrogen Receptor alpha signaling pathway in ER positive breast cancer cells. Biochem Biophys Res Commun 2016;474:400-5. [PMID: 27125460 DOI: 10.1016/j.bbrc.2016.04.132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
196 Jeon BN, Kim MK, Yoon JH, Kim MY, An H, Noh HJ, Choi WI, Koh DI, Hur MW. Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress. Nucleic Acids Res 2014;42:11447-61. [PMID: 25245946 DOI: 10.1093/nar/gku857] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
197 Tannour-Louet M, York B, Tang K, Stashi E, Bouguerra H, Zhou S, Yu H, Wong LJ, Stevens RD, Xu J, Newgard CB, O'Malley BW, Louet JF. Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis. Mol Endocrinol 2014;28:1707-18. [PMID: 25148457 DOI: 10.1210/me.2014-1083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
198 Rajendran R, Krstic-Demonacos M, Demonacos C. Regulation of the cell fate by DNA damage and hypoxia. World J Med Genet 2013; 3(4): 34-40 [DOI: 10.5496/wjmg.v3.i4.34] [Reference Citation Analysis]
199 Zhao Z, Zhang X, Wen L, Yi S, Hu J, Ruan J, Zhao F, Cui G, Fang J, Chen Y. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation. Eur J Pharmacol 2016;789:46-59. [PMID: 27370960 DOI: 10.1016/j.ejphar.2016.06.048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
200 Currey L, Thor S, Piper M. TEAD family transcription factors in development and disease. Development 2021;148:dev196675. [PMID: 34128986 DOI: 10.1242/dev.196675] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
201 Chen W, Lu X, Chen Y, Li M, Mo P, Tong Z, Wang W, Wan W, Su G, Xu J, Yu C. Steroid Receptor Coactivator 3 Contributes to Host Defense against Enteric Bacteria by Recruiting Neutrophils via Upregulation of CXCL2 Expression. J Immunol 2017;198:1606-15. [PMID: 28053238 DOI: 10.4049/jimmunol.1600300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
202 Rohira AD, Lonard DM. Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers. Biochemical Pharmacology 2017;140:1-7. [DOI: 10.1016/j.bcp.2017.04.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
203 Knutson TP, Lange CA. Dynamic regulation of steroid hormone receptor transcriptional activity by reversible SUMOylation. Vitam Horm 2013;93:227-61. [PMID: 23810010 DOI: 10.1016/B978-0-12-416673-8.00008-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
204 Wendlandt AE, Yelton SM, Lou D, Watt DS, Noonan DJ. Synthesis and functional analysis of novel bivalent estrogens. Steroids 2010;75:825-33. [PMID: 20685325 DOI: 10.1016/j.steroids.2010.05.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
205 Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol 2017;18:159-74. [PMID: 28053348 DOI: 10.1038/nrm.2016.152] [Cited by in Crossref: 193] [Cited by in F6Publishing: 186] [Article Influence: 38.6] [Reference Citation Analysis]
206 Park YY, Kim K, Kim SB, Hennessy BT, Kim SM, Park ES, Lim JY, Li J, Lu Y, Gonzalez-Angulo AM, Jeong W, Mills GB, Safe S, Lee JS. Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer. EMBO Mol Med 2012;4:52-67. [PMID: 22174013 DOI: 10.1002/emmm.201100187] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
207 Vélot L, Lessard F, Bérubé-Simard FA, Tav C, Neveu B, Teyssier V, Boudaoud I, Dionne U, Lavoie N, Bilodeau S, Pouliot F, Bisson N. Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner. Mol Cell Proteomics 2021;20:100064. [PMID: 33640491 DOI: 10.1016/j.mcpro.2021.100064] [Reference Citation Analysis]
208 Su KM, Gao HW, Chang CM, Lu KH, Yu MH, Lin YH, Liu LC, Chang CC, Li YF, Chang CC. Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis. Biomedicines 2021;9:866. [PMID: 34440070 DOI: 10.3390/biomedicines9080866] [Reference Citation Analysis]
209 Dabydeen SA, Furth PA. Genetically engineered ERα-positive breast cancer mouse models. Endocr Relat Cancer 2014;21:R195-208. [PMID: 24481326 DOI: 10.1530/ERC-13-0512] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
210 Wang B, Ye Y, Yang X, Liu B, Wang Z, Chen S, Jiang K, Zhang W, Jiang H, Mustonen H, Puolakkainen P, Wang S, Luo J, Shen Z. SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases. EMBO Rep 2020;21:e48183. [PMID: 32141187 DOI: 10.15252/embr.201948183] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
211 Amazit L, Roseau A, Khan JA, Chauchereau A, Tyagi RK, Loosfelt H, Leclerc P, Lombès M, Guiochon-Mantel A. Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity. Mol Endocrinol 2011;25:394-408. [PMID: 21273440 DOI: 10.1210/me.2010-0458] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
212 Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches. F1000Res 2021;10:127. [PMID: 33968364 DOI: 10.12688/f1000research.50850.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Hu ZZ, Kagan BL, Ariazi EA, Rosenthal DS, Zhang L, Li JV, Huang H, Wu C, Jordan VC, Riegel AT, Wellstein A. Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells. PLoS One 2011;6:e20410. [PMID: 21738574 DOI: 10.1371/journal.pone.0020410] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
214 Power PF, Mak IW, Singh S, Popovic S, Gladdy R, Ghert M. ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma. J Orthop Res 2013;31:493-501. [PMID: 22968857 DOI: 10.1002/jor.22227] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
215 Maik-Rachline G, Lifshits L, Seger R. Nuclear P38: Roles in Physiological and Pathological Processes and Regulation of Nuclear Translocation. Int J Mol Sci 2020;21:E6102. [PMID: 32847129 DOI: 10.3390/ijms21176102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
216 Lee WK, Cheng SY. Targeting transcriptional regulators for treatment of anaplastic thyroid cancer. J Cancer Metastasis Treat 2021;7:27. [PMID: 34761120 DOI: 10.20517/2394-4722.2021.58] [Reference Citation Analysis]
217 Yoo HM, Kang SH, Kim JY, Lee JE, Seong MW, Lee SW, Ka SH, Sou YS, Komatsu M, Tanaka K, Lee ST, Noh DY, Baek SH, Jeon YJ, Chung CH. Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development. Mol Cell 2014;56:261-74. [PMID: 25219498 DOI: 10.1016/j.molcel.2014.08.007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 11.3] [Reference Citation Analysis]
218 Marquis M, Boulet S, Mathien S, Rousseau J, Thébault P, Daudelin JF, Rooney J, Turgeon B, Beauchamp C, Meloche S, Labrecque N. The non-classical MAP kinase ERK3 controls T cell activation. PLoS One 2014;9:e86681. [PMID: 24475167 DOI: 10.1371/journal.pone.0086681] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
219 Copeland BT, Pal SK, Bolton EC, Jones JO. The androgen receptor malignancy shift in prostate cancer. Prostate 2018;78:521-31. [PMID: 29473182 DOI: 10.1002/pros.23497] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
220 Chan SC, Dehm SM. Constitutive activity of the androgen receptor. Adv Pharmacol 2014;70:327-66. [PMID: 24931201 DOI: 10.1016/B978-0-12-417197-8.00011-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 6.1] [Reference Citation Analysis]
221 Zhang X, Tanaka K, Yan J, Li J, Peng D, Jiang Y, Yang Z, Barton MC, Wen H, Shi X. Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation. Proc Natl Acad Sci U S A 2013;110:17284-9. [PMID: 24101509 DOI: 10.1073/pnas.1307959110] [Cited by in Crossref: 100] [Cited by in F6Publishing: 90] [Article Influence: 11.1] [Reference Citation Analysis]
222 Madan RA, Pal SK, Sartor O, Dahut WL. Overcoming chemotherapy resistance in prostate cancer. Clin Cancer Res 2011;17:3892-902. [PMID: 21680545 DOI: 10.1158/1078-0432.CCR-10-2654] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
223 Saenz FR, Ory V, Schmidt MO, Kallakury BV, Mueller SC, Furth PA, Wellstein A, Riegel AT. Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer. Neoplasia 2019;21:963-73. [PMID: 31437536 DOI: 10.1016/j.neo.2019.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
224 Kalet BT, Anglin SR, Handschy A, O'Donoghue LE, Halsey C, Chubb L, Korch C, Duval DL. Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors. PLoS One 2013;8:e68815. [PMID: 23874775 DOI: 10.1371/journal.pone.0068815] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
225 Ferry C, Gaouar S, Fischer B, Boeglin M, Paul N, Samarut E, Piskunov A, Pankotai-Bodo G, Brino L, Rochette-Egly C. Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response. Proc Natl Acad Sci U S A 2011;108:20603-8. [PMID: 22147914 DOI: 10.1073/pnas.1102572108] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
226 Chen L, Wang C, Zhang X, Gao K, Liu R, Shi B, Hou P. AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients. J Cancer 2016;7:2052-60. [PMID: 27877220 DOI: 10.7150/jca.16069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
227 Chen J, Mishra R, Yu Y, McDonald JG, Eckert KM, Gao L, Mendelson CR. Decreased 11β-hydroxysteroid dehydrogenase 1 in lungs of steroid receptor coactivator (Src)-1/-2 double-deficient fetal mice is caused by impaired glucocorticoid and cytokine signaling. FASEB J 2020;34:16243-61. [PMID: 33070362 DOI: 10.1096/fj.202001809R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Crowley F, Sterpi M, Buckley C, Margetich L, Handa S, Dovey Z. A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer. Res Rep Urol 2021;13:457-72. [PMID: 34235102 DOI: 10.2147/RRU.S264722] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
229 Kumar R, McEwan IJ. Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation. Endocr Rev 2012;33:271-99. [PMID: 22433123 DOI: 10.1210/er.2011-1033] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 8.6] [Reference Citation Analysis]
230 Lee MT, Leung YK, Chung I, Tarapore P, Ho SM. Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent manner. J Biol Chem 2013;288:25038-52. [PMID: 23857583 DOI: 10.1074/jbc.M113.476952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
231 Dasgupta S, Rajapakshe K, Zhu B, Nikolai BC, Yi P, Putluri N, Choi JM, Jung SY, Coarfa C, Westbrook TF, Zhang XH, Foulds CE, Tsai SY, Tsai MJ, O'Malley BW. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 2018;556:249-54. [PMID: 29615789 DOI: 10.1038/s41586-018-0018-1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 19.3] [Reference Citation Analysis]
232 Fontana F, Limonta P. Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer. Cells 2021;10:1133. [PMID: 34067217 DOI: 10.3390/cells10051133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Xia X, Chen Y, Xu J, Yu C, Chen W. SRC-3 deficiency protects host from Listeria monocytogenes infection through increasing ROS production and decreasing lymphocyte apoptosis. Int Immunopharmacol 2021;96:107625. [PMID: 33857803 DOI: 10.1016/j.intimp.2021.107625] [Reference Citation Analysis]
234 Yoo HM, Park JH, Jeon YJ, Chung CH. Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer. Front Endocrinol (Lausanne) 2015;6:36. [PMID: 25852645 DOI: 10.3389/fendo.2015.00036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
235 Johnson AB, O'Malley BW. Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol Cell Endocrinol 2012;348:430-9. [PMID: 21664237 DOI: 10.1016/j.mce.2011.04.021] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 9.0] [Reference Citation Analysis]
236 Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, Liao L, Xu J. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration. Cancer Res 2011;71:1742-51. [PMID: 21343398 DOI: 10.1158/0008-5472.CAN-10-3453] [Cited by in Crossref: 63] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
237 Wei Y, Xu X. UFMylation: A Unique & Fashionable Modification for Life. Genomics Proteomics Bioinformatics 2016;14:140-6. [PMID: 27212118 DOI: 10.1016/j.gpb.2016.04.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
238 Varešlija D, Ward E, Purcell SP, Cosgrove NS, Cocchiglia S, O'Halloran PJ, Charmsaz S, Bane FT, Brett FM, Farrell M, Cryan J, Beausang A, Hudson L, Turnbul AK, Dixon JM, Hill ADK, Priedigkeit N, Oesterreich S, Lee AV, Sims AH, Redmond AM, Carroll JS, Young LS. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype. Oncogene 2021;40:1318-31. [PMID: 33420368 DOI: 10.1038/s41388-020-01606-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Chen Q, Li W, Wan Y, Xia X, Wu Q, Chen Y, Lai Z, Yu C, Li W. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways. Hepatology 2012;55:1820-9. [PMID: 22213475 DOI: 10.1002/hep.25549] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
240 Blattner M, Liu D, Robinson BD, Huang D, Poliakov A, Gao D, Nataraj S, Deonarine LD, Augello MA, Sailer V, Ponnala L, Ittmann M, Chinnaiyan AM, Sboner A, Chen Y, Rubin MA, Barbieri CE. SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. Cancer Cell 2017;31:436-51. [PMID: 28292441 DOI: 10.1016/j.ccell.2017.02.004] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 17.2] [Reference Citation Analysis]
241 Chen S, Hu M, Shen M, Wang S, Wang C, Chen F, Tang Y, Wang X, Zeng H, Chen M, Gao J, Wang F, Su Y, Xu Y, Wang J. IGF-1 facilitates thrombopoiesis primarily through Akt activation. Blood 2018;132:210-22. [DOI: 10.1182/blood-2018-01-825927] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
242 Bauer V, Schmidtgall B, Gógl G, Dolenc J, Osz J, Nominé Y, Kostmann C, Cousido-Siah A, Mitschler A, Rochel N, Travé G, Kieffer B, Torbeev V. Conformational editing of intrinsically disordered protein by α-methylation. Chem Sci 2020;12:1080-9. [PMID: 34163874 DOI: 10.1039/d0sc04482b] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Wang C, Tian L, Popov VM, Pestell RG. Acetylation and nuclear receptor action. J Steroid Biochem Mol Biol 2011;123:91-100. [PMID: 21167281 DOI: 10.1016/j.jsbmb.2010.12.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
244 Song X, Chen J, Zhao M, Zhang C, Yu Y, Lonard DM, Chow DC, Palzkill T, Xu J, O'Malley BW, Wang J. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3. Proc Natl Acad Sci U S A 2016;113:4970-5. [PMID: 27084884 DOI: 10.1073/pnas.1604274113] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
245 Kumar R. Role of conformational dynamics and flexibilities in the steroid receptor-coregulator protein complex formation. Gen Comp Endocrinol 2021;309:113780. [PMID: 33882296 DOI: 10.1016/j.ygcen.2021.113780] [Reference Citation Analysis]
246 Guo P, Chen Q, Peng K, Xie J, Liu J, Ren W, Tong Z, Li M, Xu J, Zhang Y, Yu C, Mo P. Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling. Oncogene 2022. [PMID: 35418691 DOI: 10.1038/s41388-022-02308-8] [Reference Citation Analysis]
247 Wadia R, Petrylak DP. New developments in the treatment of castration resistant prostate cancer. Asian J Androl 2014;16:555-60. [PMID: 24759588 DOI: 10.4103/1008-682X.127824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
248 Wang L, Yu Y, Chow DC, Yan F, Hsu CC, Stossi F, Mancini MA, Palzkill T, Liao L, Zhou S, Xu J, Lonard DM, O'Malley BW. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death. Cancer Cell 2015;28:240-52. [PMID: 26267537 DOI: 10.1016/j.ccell.2015.07.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
249 York B, Yu C, Sagen JV, Liu Z, Nikolai BC, Wu RC, Finegold M, Xu J, O'Malley BW. Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proc Natl Acad Sci U S A 2010;107:11122-7. [PMID: 20534466 DOI: 10.1073/pnas.1005262107] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
250 Wang Z, Yang L, Song J, Kang L, Zhou S. An isoform of Taiman that contains a PRD-repeat motif is indispensable for transducing the vitellogenic juvenile hormone signal in Locusta migratoria. Insect Biochem Mol Biol 2017;82:31-40. [PMID: 28137505 DOI: 10.1016/j.ibmb.2017.01.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
251 Ribas R, Ghazoui Z, Gao Q, Pancholi S, Rani A, Dunbier A, Dowsett M, Martin LA. Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers. Breast Cancer Res. 2014;16:447. [PMID: 25358600 DOI: 10.1186/s13058-014-0447-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
252 Sun Z, Xu Y. Nuclear Receptor Coactivators (NCOAs) and Corepressors (NCORs) in the Brain. Endocrinology 2020;161:bqaa083. [PMID: 32449767 DOI: 10.1210/endocr/bqaa083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
253 Ianculescu I, Wu DY, Siegmund KD, Stallcup MR. Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells. J Biol Chem. 2012;287:4000-4013. [PMID: 22174411 DOI: 10.1074/jbc.m111.300194] [Cited by in Crossref: 77] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
254 Lee WK, Kim WG, Fozzatti L, Park S, Zhao L, Willingham MC, Lonard D, O'Malley BW, Cheng SY. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer. Endocr Relat Cancer 2020;27:209-20. [PMID: 31977311 DOI: 10.1530/ERC-19-0482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
255 Narayanan R, Jiang J, Gusev Y, Jones A, Kearbey JD, Miller DD, Schmittgen TD, Dalton JT. MicroRNAs are mediators of androgen action in prostate and muscle. PLoS One 2010;5:e13637. [PMID: 21048966 DOI: 10.1371/journal.pone.0013637] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
256 Fancher AT, Hua Y, Strock CJ, Johnston PA. Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor. Assay Drug Dev Technol 2019;17:364-86. [PMID: 31502857 DOI: 10.1089/adt.2019.940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Dobrovolna J, Chinenov Y, Kennedy MA, Liu B, Rogatsky I. Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1. Mol Cell Biol 2012;32:730-9. [PMID: 22158970 DOI: 10.1128/MCB.06473-11] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
258 Salah Z, Uziely B, Jaber M, Maoz M, Cohen I, Hamburger T, Maly B, Peretz T, Bar-Shavit R. Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen. FASEB J 2012;26:2031-42. [PMID: 22291441 DOI: 10.1096/fj.11-194704] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
259 Doggrell SA. Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer. Expert Opin Ther Targets 2011;15:1419-22. [PMID: 22035450 DOI: 10.1517/14728222.2011.632633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
260 Barua D, Gupta A, Gupta S. Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges. Cancer Lett 2020;486:29-37. [PMID: 32446861 DOI: 10.1016/j.canlet.2020.05.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
261 Li L, Deng CX, Chen Q. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer. Int J Mol Sci 2021;22:4760. [PMID: 33946224 DOI: 10.3390/ijms22094760] [Reference Citation Analysis]
262 Chen W, Zhuo M, Lu X, Xia X, Zhao Y, Huang Z, Xu J, Li W, Yu C. SRC-3 protects intestine from DSS-induced colitis by inhibiting inflammation and promoting goblet cell differentiation through enhancement of KLF4 expression. Int J Biol Sci 2018;14:2051-64. [PMID: 30585268 DOI: 10.7150/ijbs.28576] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
263 Song X, Zhang C, Zhao M, Chen H, Liu X, Chen J, Lonard DM, Qin L, Xu J, Wang X, Li F, O'Malley BW, Wang J. Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug. PLoS One 2015;10:e0140011. [PMID: 26431029 DOI: 10.1371/journal.pone.0140011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
264 Tong Z, Liu Y, Yu X, Martinez JD, Xu J. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions. J Biol Chem 2019;294:19667-82. [PMID: 31744881 DOI: 10.1074/jbc.RA119.010704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Wang Y, Kumar S, Rachagani S, Sajja BR, Xie Y, Hang Y, Jain M, Li J, Boska MD, Batra SK, Oupický D. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis. Biomaterials 2016;101:108-20. [PMID: 27267632 DOI: 10.1016/j.biomaterials.2016.05.042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
266 Adikesavan AK, Karmakar S, Pardo P, Wang L, Liu S, Li W, Smith CL. Activation of p53 transcriptional activity by SMRT: a histone deacetylase 3-independent function of a transcriptional corepressor. Mol Cell Biol 2014;34:1246-61. [PMID: 24449765 DOI: 10.1128/MCB.01216-13] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
267 Shi J, Liu W, Sui F, Lu R, He Q, Yang Q, Lv H, Shi B, Hou P. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer. Oncotarget 2015;6:14344-59. [PMID: 25970779 DOI: 10.18632/oncotarget.3852] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
268 Mullany LK, Lonard DM, O’malley BW. Wound Healing-related Functions of the p160 Steroid Receptor Coactivator Family. Endocrinology 2021;162:bqaa232. [DOI: 10.1210/endocr/bqaa232] [Reference Citation Analysis]
269 Coutinho I, Day TK, Tilley WD, Selth LA. Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Endocr Relat Cancer 2016;23:T179-97. [PMID: 27799360 DOI: 10.1530/ERC-16-0422] [Cited by in Crossref: 87] [Cited by in F6Publishing: 55] [Article Influence: 14.5] [Reference Citation Analysis]
270 Ory V, Tassi E, Cavalli LR, Sharif GM, Saenz F, Baker T, Schmidt MO, Mueller SC, Furth PA, Wellstein A. The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ. Oncogene. 2014;33:3033-3042. [PMID: 23851504 DOI: 10.1038/onc.2013.263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
271 Khurana S, Chakraborty S, Cheng X, Su YT, Kao HY. The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells. J Biol Chem 2011;286:1850-9. [PMID: 21078666 DOI: 10.1074/jbc.M110.162107] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
272 Nag JK, Bar-Shavit R. Transcriptional Landscape of PARs in Epithelial Malignancies. Int J Mol Sci 2018;19:E3451. [PMID: 30400241 DOI: 10.3390/ijms19113451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
273 Qin L, Xu Y, Xu Y, Ma G, Liao L, Wu Y, Li Y, Wang X, Wang X, Jiang J, Wang J, Xu J. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription. Oncotarget 2015;6:23890-904. [PMID: 26287601 DOI: 10.18632/oncotarget.4341] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
274 Hu C, Lau AJ, Wang R, Chang TK. Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression. European Journal of Pharmacology 2017;815:501-11. [DOI: 10.1016/j.ejphar.2017.10.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
275 Kiriyama Y, Nochi H. Physiological Role of Bile Acids Modified by the Gut Microbiome. Microorganisms 2021;10:68. [PMID: 35056517 DOI: 10.3390/microorganisms10010068] [Reference Citation Analysis]
276 Walsh CA, Qin L, Tien JC, Young LS, Xu J. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci 2012;8:470-85. [PMID: 22419892 DOI: 10.7150/ijbs.4125] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
277 Thomas C, Gustafsson JÅ. The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 2011;11:597-608. [PMID: 21779010 DOI: 10.1038/nrc3093] [Cited by in Crossref: 401] [Cited by in F6Publishing: 382] [Article Influence: 36.5] [Reference Citation Analysis]
278 Fan P, Craig Jordan V. Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations. Steroids 2014;90:44-52. [PMID: 24930824 DOI: 10.1016/j.steroids.2014.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
279 Störchel PH, Thümmler J, Siegel G, Aksoy-Aksel A, Zampa F, Sumer S, Schratt G. A large-scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function. EMBO J 2015;34:2237-54. [PMID: 26105073 DOI: 10.15252/embj.201490643] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
280 Reddy D, Kumavath R, Barh D, Azevedo V, Ghosh P. Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions. Molecules 2020;25:E3596. [PMID: 32784680 DOI: 10.3390/molecules25163596] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
281 Balasubramaniyan N, Luo Y, Sun AQ, Suchy FJ. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes. J Biol Chem 2013;288:13850-62. [PMID: 23546875 DOI: 10.1074/jbc.M112.443937] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
282 Lydon JP, O'Malley BW. Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology 2011;152:19-25. [PMID: 21047941 DOI: 10.1210/en.2010-1012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
283 Tien JC, Liu Z, Liao L, Wang F, Xu Y, Wu YL, Zhou N, Ittmann M, Xu J. The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer. Cancer Res 2013;73:3997-4008. [PMID: 23650284 DOI: 10.1158/0008-5472.CAN-12-3929] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
284 Karmakar S, Foster EA, Blackmore JK, Smith CL. Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line. Endocr Relat Cancer 2011;18:113-27. [PMID: 21059860 DOI: 10.1677/ERC-09-0285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
285 Liu R, Gao J, Yang Y, Qiu R, Zheng Y, Huang W, Zeng Y, Hou Y, Wang S, Leng S, Feng D, Yu W, Sun G, Shi H, Teng X, Wang Y. PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis. Nucleic Acids Res 2018;46:6608-26. [PMID: 29846670 DOI: 10.1093/nar/gky461] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
286 Khani F, Mosquera JM, Park K, Blattner M, O'Reilly C, MacDonald TY, Chen Z, Srivastava A, Tewari AK, Barbieri CE, Rubin MA, Robinson BD. Evidence for molecular differences in prostate cancer between African American and Caucasian men. Clin Cancer Res 2014;20:4925-34. [PMID: 25056375 DOI: 10.1158/1078-0432.CCR-13-2265] [Cited by in Crossref: 94] [Cited by in F6Publishing: 70] [Article Influence: 11.8] [Reference Citation Analysis]
287 Li Q, Xu J. Identification and characterization of the alternatively spliced nuclear receptor coactivator-6 isoforms. Int J Biol Sci 2011;7:505-16. [PMID: 21552418 DOI: 10.7150/ijbs.7.505] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
288 Sun J, Sun WJ, Li ZY, Li L, Wang Y, Zhao Y, Wang C, Yu LR, Li LZ, Zhang YL. Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. Int Immunopharmacol 2016;40:32-40. [PMID: 27576059 DOI: 10.1016/j.intimp.2016.08.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
289 Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 2012;22:90-106. [PMID: 21876555 DOI: 10.1038/cr.2011.144] [Cited by in Crossref: 222] [Cited by in F6Publishing: 233] [Article Influence: 20.2] [Reference Citation Analysis]
290 Rogatsky I, Adelman K. Preparing the first responders: building the inflammatory transcriptome from the ground up. Mol Cell 2014;54:245-54. [PMID: 24766888 DOI: 10.1016/j.molcel.2014.03.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
291 Lacambra MD, Weinreb I, Demicco EG, Chow C, Sung YS, Swanson D, To KF, Wong KC, Antonescu CR, Dickson BC. PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm. Genes Chromosomes Cancer 2019;58:705-12. [PMID: 31008539 DOI: 10.1002/gcc.22762] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
292 Li M, Liu P, Wiley JD, Ojani R, Bevan DR, Li J, Zhu J. A steroid receptor coactivator acts as the DNA-binding partner of the methoprene-tolerant protein in regulating juvenile hormone response genes. Mol Cell Endocrinol 2014;394:47-58. [PMID: 25004255 DOI: 10.1016/j.mce.2014.06.021] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
293 Yao C, Su L, Zhang F, Zhu X, Zhu Y, Wei L, Jiao X, Hou Y, Chen X, Wang W, Wang J, Zhu X, Zou C, Zhu S, Xu Z. Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis. Cancer Lett 2020;493:167-77. [PMID: 32829007 DOI: 10.1016/j.canlet.2020.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
294 Rines AK, Sharabi K, Tavares CD, Puigserver P. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov. 2016;15:786-804. [PMID: 27516169 DOI: 10.1038/nrd.2016.151] [Cited by in Crossref: 138] [Cited by in F6Publishing: 126] [Article Influence: 23.0] [Reference Citation Analysis]
295 Guo M, Chen Y, Chen Q, Guo X, Yuan Z, Kang L, Jiang Y. Epigenetic changes associated with increased estrogen receptor alpha mRNA transcript abundance during reproductive maturation in chicken ovaries. Anim Reprod Sci 2020;214:106287. [PMID: 32087914 DOI: 10.1016/j.anireprosci.2020.106287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
296 Pfaff D, Waters E, Khan Q, Zhang X, Numan M. Minireview: estrogen receptor-initiated mechanisms causal to mammalian reproductive behaviors. Endocrinology 2011;152:1209-17. [PMID: 21325045 DOI: 10.1210/en.2010-1007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
297 Triki M, Lapierre M, Cavailles V, Mokdad-Gargouri R. Expression and role of nuclear receptor coregulators in colorectal cancer. World J Gastroenterol 2017; 23(25): 4480-4490 [PMID: 28740336 DOI: 10.3748/wjg.v23.i25.4480] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
298 Zheng X, Jia Y, Qiu L, Zeng X, Xu L, Wei M, Huang C, Liu C, Chen L, Han J. A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator. J Biol Chem 2020;295:1474-88. [PMID: 31914406 DOI: 10.1074/jbc.RA119.009899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
299 Pan Y, Tsai CJ, Ma B, Nussinov R. Mechanisms of transcription factor selectivity. Trends Genet 2010;26:75-83. [PMID: 20074831 DOI: 10.1016/j.tig.2009.12.003] [Cited by in Crossref: 100] [Cited by in F6Publishing: 98] [Article Influence: 8.3] [Reference Citation Analysis]
300 Bian C, Zhu H, Zhao Y, Cai W, Zhang J. Intriguing roles of hippocampus-synthesized 17β-estradiol in the modulation of hippocampal synaptic plasticity. J Mol Neurosci 2014;54:271-81. [PMID: 24729128 DOI: 10.1007/s12031-014-0285-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
301 Ahmad N, Kumar R. Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Lett. 2011;300:1-9. [PMID: 20926181 DOI: 10.1016/j.canlet.2010.09.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 6.3] [Reference Citation Analysis]
302 Teske KA, Yu O, Arnold LA. Inhibitors for the Vitamin D Receptor-Coregulator Interaction. Vitam Horm 2016;100:45-82. [PMID: 26827948 DOI: 10.1016/bs.vh.2015.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
303 Li Z, Fang ZY, Ding Y, Yao WT, Yang Y, Zhu ZQ, Wang W, Zhang QX. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population. World J Gastroenterol 2012; 18(8): 855-860 [PMID: 22371647 DOI: 10.3748/wjg.v18.i8.855] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
304 Rubio MF, Lira MC, Rosa FD, Sambresqui AD, Salazar Güemes MC, Costas MA. RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition. Cancer Cell Int 2017;17:111. [PMID: 29209153 DOI: 10.1186/s12935-017-0483-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
305 Hu M, Zeng H, Chen S, Xu Y, Wang S, Tang Y, Wang X, Du C, Shen M, Chen F, Chen M, Wang C, Gao J, Wang F, Su Y, Wang J. SRC-3 is involved in maintaining hematopoietic stem cell quiescence by regulation of mitochondrial metabolism in mice. Blood. 2018;132:911-923. [PMID: 29959189 DOI: 10.1182/blood-2018-02-831669] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
306 Chien CD, Kirilyuk A, Li JV, Zhang W, Lahusen T, Schmidt MO, Oh AS, Wellstein A, Riegel AT. Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription. J Biol Chem 2011;286:26813-27. [PMID: 21636853 DOI: 10.1074/jbc.M110.216200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
307 Chen HY, Chen RH. Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications. Front Oncol 2016;6:113. [PMID: 27200299 DOI: 10.3389/fonc.2016.00113] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
308 Xu C, Ochi H, Fukuda T, Sato S, Sunamura S, Takarada T, Hinoi E, Okawa A, Takeda S. Circadian Clock Regulates Bone Resorption in Mice. J Bone Miner Res 2016;31:1344-55. [PMID: 26841172 DOI: 10.1002/jbmr.2803] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
309 Seruga B, Ocana A, Tannock IF. Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol. 2011;8:12-23. [PMID: 20859283 DOI: 10.1038/nrclinonc.2010.136] [Cited by in Crossref: 204] [Cited by in F6Publishing: 200] [Article Influence: 17.0] [Reference Citation Analysis]
310 El Beaino M, Roszik J, Livingston JA, Wang WL, Lazar AJ, Amini B, Subbiah V, Lewis V, Conley AP. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology. Curr Oncol Rep 2018;20:37. [PMID: 29582189 DOI: 10.1007/s11912-018-0668-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
311 Mendelson CR, Montalbano AP, Gao L. Fetal-to-maternal signaling in the timing of birth. J Steroid Biochem Mol Biol 2017;170:19-27. [PMID: 27629593 DOI: 10.1016/j.jsbmb.2016.09.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
312 Groner AC, Brown M. Role of steroid receptor and coregulator mutations in hormone-dependent cancers. J Clin Invest 2017;127:1126-35. [PMID: 28368289 DOI: 10.1172/JCI88885] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 6.2] [Reference Citation Analysis]
313 Dzieran J, Rodriguez Garcia A, Westermark UK, Henley AB, Eyre Sánchez E, Träger C, Johansson HJ, Lehtiö J, Arsenian-Henriksson M. MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling. Proc Natl Acad Sci U S A 2018;115:E1229-38. [PMID: 29374092 DOI: 10.1073/pnas.1710901115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
314 Lavery DN, Villaronga MA, Walker MM, Patel A, Belandia B, Bevan CL. Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors. J Biol Chem. 2011;286:17796-17808. [PMID: 21454491 DOI: 10.1074/jbc.m110.198655] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
315 Chen Y, Shao X, Cao J, Zhu H, Yang B, He Q, Ying M. Phosphorylation regulates cullin-based ubiquitination in tumorigenesis. Acta Pharm Sin B 2021;11:309-21. [PMID: 33643814 DOI: 10.1016/j.apsb.2020.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
316 Foley C, Mitsiades N. Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer. Horm Cancer 2016;7:84-103. [PMID: 26728473 DOI: 10.1007/s12672-015-0239-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
317 Luo A, Su D, Zhang X, Qi L, Fu L, Dong J. Estrogen-estrogen receptor signaling suppresses the transcription of ERRF in breast cancer cells. Journal of Genetics and Genomics 2016;43:565-7. [DOI: 10.1016/j.jgg.2016.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
318 Zwart W, Theodorou V, Kok M, Canisius S, Linn S, Carroll JS. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. EMBO J 2011;30:4764-76. [PMID: 22002538 DOI: 10.1038/emboj.2011.368] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 8.3] [Reference Citation Analysis]
319 Gargaro M, Scalisi G, Manni G, Mondanelli G, Grohmann U, Fallarino F. The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions. Int J Mol Sci 2021;22:E757. [PMID: 33451129 DOI: 10.3390/ijms22020757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
320 Brisken C, O’Malley B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2010;2:a003178. [PMID: 20739412 DOI: 10.1101/cshperspect.a003178] [Cited by in Crossref: 250] [Cited by in F6Publishing: 241] [Article Influence: 20.8] [Reference Citation Analysis]
321 Jeninga EH, Schoonjans K, Auwerx J. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 2010;29:4617-24. [PMID: 20531298 DOI: 10.1038/onc.2010.206] [Cited by in Crossref: 109] [Cited by in F6Publishing: 101] [Article Influence: 9.1] [Reference Citation Analysis]
322 Cussol L, Mauran‐ambrosino L, Buratto J, Belorusova AY, Neuville M, Osz J, Fribourg S, Fremaux J, Dolain C, Goudreau SR, Rochel N, Guichard G. Structural Basis for α‐Helix Mimicry and Inhibition of Protein–Protein Interactions with Oligourea Foldamers. Angew Chem 2021;133:2326-33. [DOI: 10.1002/ange.202008992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
323 Oh S, Shin S, Janknecht R. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta. 2012;1826:1-12. [PMID: 22425584 DOI: 10.1016/j.bbcan.2012.02.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 121] [Article Influence: 4.0] [Reference Citation Analysis]
324 Krausova L, Stejskalova L, Wang H, Vrzal R, Dvorak Z, Mani S, Pavek P. Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene. Biochem Pharmacol 2011;82:1771-80. [PMID: 21920351 DOI: 10.1016/j.bcp.2011.08.023] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
325 Kopczynski J, Kowalik A, Chłopek M, Wang ZF, Góźdź S, Lasota J, Miettinen M. Oncogenic Activation of the Wnt/β-Catenin Signaling Pathway in Signet Ring Stromal Cell Tumor of the Ovary. Appl Immunohistochem Mol Morphol 2016;24:e28-33. [PMID: 26509912 DOI: 10.1097/PAI.0000000000000271] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
326 Elkhadragy L, Alsaran H, Long W. The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion. Int J Mol Sci 2020;21:E4044. [PMID: 32516969 DOI: 10.3390/ijms21114044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Agbo L, Lambert J. Proteomics contribution to the elucidation of the steroid hormone receptors functions. The Journal of Steroid Biochemistry and Molecular Biology 2019;192:105387. [DOI: 10.1016/j.jsbmb.2019.105387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
328 Liu J, Xie Y, Guo J, Li X, Wang J, Jiang H, Peng Z, Wang J, Wang S, Li Q, Ye L, Zhong Y, Zhang Q, Liu X, Lonard DM, Wang J, O'Malley BW, Liu Z. Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun 2021;12:1022. [PMID: 33589584 DOI: 10.1038/s41467-021-21386-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
329 Tsai CH, Li CH, Liao PL, Cheng YW, Lin CH, Huang SH, Kang JJ. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR. Toxicol Sci 2015;148:517-30. [PMID: 26350169 DOI: 10.1093/toxsci/kfv199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
330 Long W, Foulds CE, Qin J, Liu J, Ding C, Lonard DM, Solis LM, Wistuba II, Qin J, Tsai SY, Tsai MJ, O'Malley BW. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J Clin Invest 2012;122:1869-80. [PMID: 22505454 DOI: 10.1172/JCI61492] [Cited by in Crossref: 73] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
331 Li Y, Liang J, Dang H, Zhang R, Chen P, Shao Y. NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways. Endocrine 2021. [PMID: 34251576 DOI: 10.1007/s12020-021-02819-6] [Reference Citation Analysis]
332 Lavery DN, Bevan CL. Androgen receptor signalling in prostate cancer: the functional consequences of acetylation. J Biomed Biotechnol 2011;2011:862125. [PMID: 21274273 DOI: 10.1155/2011/862125] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
333 Gao L, Rabbitt EH, Condon JC, Renthal NE, Johnston JM, Mitsche MA, Chambon P, Xu J, O'Malley BW, Mendelson CR. Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition. J Clin Invest 2015;125:2808-24. [PMID: 26098214 DOI: 10.1172/JCI78544] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 7.3] [Reference Citation Analysis]
334 Cucchiara V, Yang JC, Mirone V, Gao AC, Rosenfeld MG, Evans CP. Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cancers (Basel) 2017;9:E9. [PMID: 28275218 DOI: 10.3390/cancers9010009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]